Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Synchron Inc, a brain chip start-up backed by Jeff Bezos and Bill Gates, is advancing in the competitive field of brain-computer interfaces. The company, a direct competitor to Elon Musk's Neuralink, is preparing to recruit patients for a large-scale clinical trial. This step is crucial for seeking commercial approval for its Stentrode microchip, a device that is inserted into the brain via a blood vessel using a catheter to pick up brainwaves. Unlike Neuralink's approach, Synchron's method is less invasive, as it does not require open-brain surgery, offering a non-invasive path. The upcoming trials aim to test the device's efficacy for stroke and multiple sclerosis (MS) patients.
🚨SYNCHRON GEARS UP FOR VEIN-TO-BRAIN IMPLANT TRIALS Synchron, a challenger to Elon's Neuralink, backed by Bezos and Gates, announced imminent brain implant trials for stroke and MS patients. Synchron's implant navigates to the brain via veins, a non-invasive path that… https://t.co/ouEXUwvb4R
Exclusive: Synchron, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company's chief executive told @Reuters https://t.co/m6wO2w0m7g
Exclusive: Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial https://t.co/xMU3wOxiJL https://t.co/FDDfXGgkrP
